ad

AksharChem Analyst Review 2027: Sales Up 80% and Profit Returns as Stock Trades Below Book

19 Nov 2026 • 2:02 pm

AksharChem Analyst Review 2027: Sales Up 80% and Profit Returns as Stock Trades Below Book

AksharChem (India) Stock Snapshot (18 Nov 2026 close)

  • Current Market Price (CMP): ₹330.65
  • 52-Week High / Low: ₹472.00 / ₹141.30
  • Market Capitalisation: About ₹265 crore
  • P/E Ratio vs Industry P/E: 9.2 vs 36.5
  • Latest Quarter (Q2 FY27) Revenue: ₹160.48 crore
  • Latest Quarter (Q2 FY27) Net Profit: ₹13.32 crore

Quick Answer: The AksharChem analyst review 2027 finds no brokerage coverage as of November 2026. Q2 FY27 sales rose about 80% to ₹160.48 crore and net profit was ₹13.32 crore, against a loss of ₹1.37 crore a year ago. That follows a June quarter with sales of about ₹141 crore and profit of ₹15.21 crore. H1 FY27 profit is about ₹28.5 crore. At ₹330.65, the stock trades at about 9.2 times trailing earnings and about 0.9 times book value, so the AksharChem share price target 2027 question depends on whether the recovery lasts.

The AksharChem analyst review 2027 covers AksharChem (India), a Gujarat-based maker of pigments and dye intermediates used in paints, inks, plastics and textiles. Readers searching for an AksharChem share price target 2027 will not find a named brokerage figure, so results and valuation guide this review.

AksharChem (India) closed at ₹330.65 on 18 November 2026, about 30% below its 52-week high of ₹472 but more than double its low of ₹141.30. This AksharChem analyst review 2027 covers the September quarter and the AksharChem stock outlook 2027.

Click Here – Get Free Investment Predictions

What Analysts Say in the AksharChem Analyst Review 2027

Brokerage Rating Target Price Date
No verified coverage Not available Not available As of November 2026

No brokerage covers AksharChem, and institutions hold less than 0.1% of the company. Its market value of about ₹265 crore keeps it outside research coverage.

Earnings and book value are the useful reference points. Trailing EPS is about ₹35.79, giving a P/E of about 9.2 against an industry level of about 36.5, and book value is about ₹361 per share. This AksharChem analyst review 2027 explains why the stock still trades below book after a strong rally.

Q2 FY27 Results in the AksharChem Analyst Review 2027

Quarter Sales Net Profit Comment
Sep 2026 (Q2 FY27) ₹160.48 crore ₹13.32 crore Sales up about 80% YoY
Jun 2026 (Q1 FY27) About ₹141 crore ₹15.21 crore Sales up about 45% YoY
Dec 2025 (Q3 FY26) ₹80.38 crore Loss of ₹4.62 crore Sales down about 11% YoY
Sep 2025 (Q2 FY26) ₹89.30 crore Loss of ₹1.37 crore Base quarter

Sales rose about 80% from a year ago to ₹160.48 crore, and net profit swung to ₹13.32 crore from a loss. Operating profit rose faster than sales, which shows a clear improvement in margins.

The turnaround came after a loss of ₹4.62 crore in the December 2025 quarter. Two strong quarters in a row make this AksharChem analyst review 2027 a recovery story rather than a one-quarter spike.

How AksharChem Makes Money

AksharChem makes colour chemicals for industrial customers in India and abroad.

  • Pigments: blue and green pigments used in paints, printing inks and plastics.
  • Dye intermediates: chemicals used to make reactive dyes for textiles.
  • Exports: sales to overseas buyers in the colour chemicals industry.
  • Domestic sales: supply to Indian paint, ink and dye makers.

Half-year sales were about ₹186 crore in H1 FY26, with a small loss of about ₹0.7 crore. In H1 FY27, sales rose to about ₹301 crore and profit to about ₹28.5 crore. That sharp swing is the core of this AksharChem analyst review 2027.

Pigment and dye intermediate makers are exposed to raw material prices, competition from Chinese suppliers and demand from paint and textile industries. When input costs fall or prices recover, profit can rise quickly because fixed costs are spread over higher volumes, which appears to be what happened in FY27.

The flip side is that this industry has been cyclical. AksharChem posted losses for much of FY26, so investors tend to value it on book value rather than on peak earnings. That is why the P/E of about 9 is well below the industry level.

The stock has more than doubled from its 52-week low but has also fallen about 30% from its high, showing how quickly sentiment can change. Return on equity was about 9.9% on trailing numbers, which is still modest for a chemicals company.

Debt to equity of about 0.36 is manageable. If the company keeps earning at the H1 FY27 pace, return on equity would rise sharply, which is the main case for the stock moving closer to or above book value.

Growth Triggers in the AksharChem Analyst Review 2027

  • Sales jump: Q2 FY27 sales up about 80%.
  • Profit recovery: H1 FY27 profit of about ₹28.5 crore after a loss a year ago.
  • Margin expansion: operating profit grew faster than sales.
  • Low valuation: a P/E near 9.2 and price below book.
  • Industry recovery: better pigment demand supports the AksharChem share price target 2027 debate.

Key Risks in the AksharChem Analyst Review 2027

  • Cyclical industry: the company posted losses through much of FY26.
  • Chinese competition: pricing pressure in colour chemicals.
  • Raw material swings: input costs can erase margins quickly.
  • Volatile stock: about 30% below its high after doubling from its low.
  • Low liquidity: almost no institutional holding, a caution in the AksharChem analyst review 2027.

Compare AksharChem With Other Chemical Stocks on the Univest Screener

AksharChem Analyst Review 2027: Stock at a Glance

Metric Value
Share Price (18 Nov 2026 close) ₹330.65
52-Week High / Low ₹472.00 / ₹141.30
Market Capitalisation About ₹265 crore
P/E (TTM) 9.2
Industry P/E 36.5
Price to Book 0.92
Book Value per Share ₹361.09
Debt to Equity 0.36
EPS (TTM) ₹35.79
H1 FY27 Sales / Net Profit About ₹301 crore / ₹28.5 crore

The P/E of about 9.2 and price to book value of about 0.92 are both low. In this AksharChem analyst review 2027, the discount reflects doubts about how long the recovery will last after a loss-making FY26.

Shareholding Trend

Holder Sep 2025 Sep 2026 Change
Promoters 62.70% 62.70% No change
Foreign Investors (FII) 0.02% 0.01% Flat
Domestic Institutions (DII) 0.06% 0.06% No change
Public 37.23% 37.24% Flat

The promoter group holds 62.7%, mainly through the Mrugesh Jaykrishna Family Trust at 38.9% and the Munjal M. Jaykrishna Family Trust at 19.9%. Unchanged holdings are a neutral point in the AksharChem analyst review 2027.

Univest iOS App

Univest Android App

What to Watch After the AksharChem Analyst Review 2027

  • December quarter: profit against last year's ₹4.62 crore loss.
  • Margins: whether operating margins hold at H1 levels.
  • Pigment prices: effect of Chinese competition.
  • Return on equity: improvement as profits rebuild.
  • Coverage: any research note would give an AksharChem share price target 2027 reference.

Final Word on the AksharChem Analyst Review 2027

The AksharChem analyst review 2027 shows a sharp recovery, with sales up 80% and profit back in the September quarter after a loss-making FY26. The stock trades near 9 times earnings and below book value.

The AksharChem stock outlook 2027 depends on whether margins and demand hold through the industry cycle. Univest does not give a buy or sell call.

Disclaimer: This article is for educational and informational purposes only and is not investment advice or a recommendation to buy, sell or hold any security. Brokerage ratings and target prices quoted here are opinions of third-party research houses; Univest does not endorse them and gives no buy or sell call. Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.

Frequently Asked Questions

What does the AksharChem analyst review 2027 show?

It shows a strong recovery. Q2 FY27 sales rose about 80% to ₹160.48 crore and net profit was ₹13.32 crore. A year earlier, the company posted a loss of ₹1.37 crore.

Is there an AksharChem share price target 2027 from brokerages?

No brokerage covers AksharChem as of November 2026. The stock closed at ₹330.65 on 18 November 2026. Book value per share is about ₹361.

What does AksharChem make?

AksharChem makes pigments and dye intermediates used in paints, printing inks, plastics and textiles. It sells in India and abroad. H1 FY27 sales were about ₹301 crore.

How much did AksharChem earn in H1 FY27?

H1 FY27 profit was about ₹28.5 crore, including ₹15.21 crore in the June quarter and ₹13.32 crore in September. H1 FY26 showed a small loss of about ₹0.7 crore. Sales rose to about ₹301 crore from about ₹186 crore.

Is AksharChem stock undervalued based on the AksharChem analyst review 2027?

The P/E is about 9.2 against an industry P/E of about 36.5. Price to book is about 0.92. The discount reflects the cyclical nature of the business.

What risks does the AksharChem analyst review 2027 highlight?

The main risks are industry cycles, Chinese competition and raw material swings. The company posted losses through much of FY26. The stock is about 30% below its 52-week high.

What should investors track after the AksharChem analyst review 2027?

Track December quarter profit against last year's ₹4.62 crore loss. Watch margins and pigment prices. Return on equity improvement also matters.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down